Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 4Wounds and Injuries 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Pain 1Nasopharyngeal Carcinoma 1Carcinoma, Squamous Cell 1Cancer Pain 1Breast Neoplasms 1Breakthrough Pain 1Agnosia 1

Interventions

Cisplatin 127Gemcitabine 71Radiotherapy, Intensity-Modulated 61toripalimab 39Capecitabine 37Docetaxel 36Fluorouracil 35Radiotherapy 24camrelizumab 23Drug Therapy 22nimotuzumab 18spartalizumab 13pembrolizumab 13nedaplatin 12Chemoradiotherapy 12sintilimab 11apatinib 11Induction Chemotherapy 11Immune Checkpoint Inhibitors 11tislelizumab 10Nivolumab 10Magnetic Resonance Spectroscopy 10Specimen Handling 9Radiation 9Cetuximab 9Carboplatin 9endostar protein 8Paclitaxel 8Bevacizumab 8anlotinib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Carcinoma × Morphine × Head & Neck × Clear all
NCT04292990 2020-07-29

Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients

Jiangmen Central Hospital

Phase 4 Unknown
300 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡